FDA Approved: ELEPSIA XR 1000 MG — Supplemental Application (TRIPOINT THERAPEUTICS, LLC)

View source ↗

Summary

FDA approved a supplemental application for ELEPSIA XR 1000 mg (levetiracetam) from Tripoint Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• ELEPSIA XR 1000 MG (LEVETIRACETAM)

Snippet

SUPPL AP for ELEPSIA XR 1000 MG (LEVETIRACETAM)